Stock SXTP 60 DEGREES PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart 60 Degrees Pharmaceuticals, Inc.

Equities

SXTP

US83006G1040

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-28 EDT 		5-day change 1st Jan Change
0.2529 USD -5.85% Intraday chart for 60 Degrees Pharmaceuticals, Inc. -10.32% -75.21%
06-27 60 Degrees Pharmaceuticals, Inc. Announces First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center CI
05-30 60 Degrees Pharmaceuticals, Inc. Enters into an Agreement with Tufts Medical Center in Boston to Conduct the First Clinical Trial of Tafenoquine in Treating Human Babesiosis Patients CI
Chart 60 Degrees Pharmaceuticals, Inc.
  1. Stock Market
  2. Equities
  3. SXTP Stock
  4. Charts 60 Degrees Pharmaceuticals, Inc.
  5. Static Chart